Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Genscript Biotech (GNNSF) Q1 2026 Earnings
GNNSF
15
Mar
Confirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.23
0.34
0.91
1.48
Details
Expected EPS
-0.03
Actual EPS
-0.23
Surprise EPS
-0.2
Surprise Percent
+666.67%
Description
Genscript Biotech (GNNSF) has reported earnings of -0.23 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login